Stay updated with breaking news from Iontech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Three child-size doses of the Pfizer/BioNTech Covid-19 vaccine appeared to be safe and showed a strong immune response in children ages 6 months to 5 years, the companies said Monday.
Pfizer conducted trials on the vaccine's effects on the age group.
Pfizer conducted trials on the vaccine's effects on the age group.
Three doses of Pfizer's COVID-19 vaccine offer strong protection for children under 5, the company says. Pfizer plans to give the data to regulators this week.
The companies said the vaccine was safe and well-tolerated by the children, and they plan to soon ask global regulators to authorize the shot for the age group.